Cargando…
Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays
Lateral flow immunoassays (LFIA) for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are used for population surveillance and potentially individual risk assessment. The performance of the SureScreen Diagnostics LFIA targeting the spike protein was evaluated in c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829606/ https://www.ncbi.nlm.nih.gov/pubmed/36716586 http://dx.doi.org/10.1016/j.diagmicrobio.2023.115900 |